In-Stent Restenosis in the United States
Authors:
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Management of myocardial revascularisation failure: an expert consensus document of the EAPCIEuroIntervention, 2020
- Influence of treatment modality and neointimal characteristics on optical coherence tomography on clinical outcomes of in-stent restenosisEuropean Heart Journal, 2020
- Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United StatesJACC, 2020
- Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent RestenosisJACC, 2020
- Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trialsThe Lancet, 2019
- Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysisThe Lancet, 2015
- Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent RestenosisJACC: Cardiovascular Interventions, 2015
- Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stentingEuropean Heart Journal, 2014
- Pathology of Drug-Eluting Stents in HumansJACC, 2006
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002